Crescent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$16.67

+0.24 (+1.46%)

As of Aug 8, 2:03 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +65.9% upside

Low Target $15.31

Average Target $27.66

High Target $30.74

Current Price $16.67

Current
$16.67

Target
$27.66

$15.31 $27.66 avg $30.74

Scenario Analysis

Bear Case

$15.31

-8.2%

Low target

Base Case

$27.66

+65.9%

Avg target

Bull Case

$30.74

+84.4%

High target

Risk/Reward

10.3x

Highly favorable

Price in Context

52-Week High

$27.41

-39.2% from high

52-Week Low

$8.72

+91.2% from low

Target vs 52W High

$27.66

+0.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%